866-997-4948(US-Canada Toll Free)

Global Biosimilar of Remicade Market Size, Status and Forecast 2018-2025

Published By :

QYResearch

Published Date : Oct 2018

Category :

Software

No. of Pages : 99 Pages

Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product.
In 2017, the global Biosimilar of Remicade market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.
This report focuses on the global Biosimilar of Remicade status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biosimilar of Remicade development in United States, Europe and China.


The key players covered in this study
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)

Market segment by Type, the product can be split into
100mg/10ml
500mg/50ml

Market segment by Application, split into
Blood Disorders
Oncology Diseases

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Biosimilar of Remicade status, future forecast, growth opportunity, key market and key players.
To present the Biosimilar of Remicade development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Biosimilar of Remicade are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Biosimilar of Remicade Market Size Growth Rate by Type (2013-2025)
1.4.2 100mg/10ml
1.4.3 500mg/50ml
1.5 Market by Application
1.5.1 Global Biosimilar of Remicade Market Share by Application (2013-2025)
1.5.2 Blood Disorders
1.5.3 Oncology Diseases
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Biosimilar of Remicade Market Size
2.2 Biosimilar of Remicade Growth Trends by Regions
2.2.1 Biosimilar of Remicade Market Size by Regions (2013-2025)
2.2.2 Biosimilar of Remicade Market Share by Regions (2013-2018)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Biosimilar of Remicade Market Size by Manufacturers
3.1.1 Global Biosimilar of Remicade Revenue by Manufacturers (2013-2018)
3.1.2 Global Biosimilar of Remicade Revenue Market Share by Manufacturers (2013-2018)
3.1.3 Global Biosimilar of Remicade Market Concentration Ratio (CR5 and HHI)
3.2 Biosimilar of Remicade Key Players Head office and Area Served
3.3 Key Players Biosimilar of Remicade Product/Solution/Service
3.4 Date of Enter into Biosimilar of Remicade Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Biosimilar of Remicade Market Size by Type (2013-2018)
4.2 Global Biosimilar of Remicade Market Size by Application (2013-2018)

5 United States
5.1 United States Biosimilar of Remicade Market Size (2013-2018)
5.2 Biosimilar of Remicade Key Players in United States
5.3 United States Biosimilar of Remicade Market Size by Type
5.4 United States Biosimilar of Remicade Market Size by Application

6 Europe
6.1 Europe Biosimilar of Remicade Market Size (2013-2018)
6.2 Biosimilar of Remicade Key Players in Europe
6.3 Europe Biosimilar of Remicade Market Size by Type
6.4 Europe Biosimilar of Remicade Market Size by Application

7 China
7.1 China Biosimilar of Remicade Market Size (2013-2018)
7.2 Biosimilar of Remicade Key Players in China
7.3 China Biosimilar of Remicade Market Size by Type
7.4 China Biosimilar of Remicade Market Size by Application

8 Japan
8.1 Japan Biosimilar of Remicade Market Size (2013-2018)
8.2 Biosimilar of Remicade Key Players in Japan
8.3 Japan Biosimilar of Remicade Market Size by Type
8.4 Japan Biosimilar of Remicade Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Biosimilar of Remicade Market Size (2013-2018)
9.2 Biosimilar of Remicade Key Players in Southeast Asia
9.3 Southeast Asia Biosimilar of Remicade Market Size by Type
9.4 Southeast Asia Biosimilar of Remicade Market Size by Application

10 India
10.1 India Biosimilar of Remicade Market Size (2013-2018)
10.2 Biosimilar of Remicade Key Players in India
10.3 India Biosimilar of Remicade Market Size by Type
10.4 India Biosimilar of Remicade Market Size by Application

11 Central & South America
11.1 Central & South America Biosimilar of Remicade Market Size (2013-2018)
11.2 Biosimilar of Remicade Key Players in Central & South America
11.3 Central & South America Biosimilar of Remicade Market Size by Type
11.4 Central & South America Biosimilar of Remicade Market Size by Application

12 International Players Profiles
12.1 Synthon Pharmaceuticals
12.1.1 Synthon Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Biosimilar of Remicade Introduction
12.1.4 Synthon Pharmaceuticals Revenue in Biosimilar of Remicade Business (2013-2018)
12.1.5 Synthon Pharmaceuticals Recent Development
12.2 LG Life Sciences
12.2.1 LG Life Sciences Company Details
12.2.2 Company Description and Business Overview
12.2.3 Biosimilar of Remicade Introduction
12.2.4 LG Life Sciences Revenue in Biosimilar of Remicade Business (2013-2018)
12.2.5 LG Life Sciences Recent Development
12.3 Novartis (Sandoz)
12.3.1 Novartis (Sandoz) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Biosimilar of Remicade Introduction
12.3.4 Novartis (Sandoz) Revenue in Biosimilar of Remicade Business (2013-2018)
12.3.5 Novartis (Sandoz) Recent Development
12.4 Celltrion
12.4.1 Celltrion Company Details
12.4.2 Company Description and Business Overview
12.4.3 Biosimilar of Remicade Introduction
12.4.4 Celltrion Revenue in Biosimilar of Remicade Business (2013-2018)
12.4.5 Celltrion Recent Development
12.5 Biocon
12.5.1 Biocon Company Details
12.5.2 Company Description and Business Overview
12.5.3 Biosimilar of Remicade Introduction
12.5.4 Biocon Revenue in Biosimilar of Remicade Business (2013-2018)
12.5.5 Biocon Recent Development
12.6 Hospira
12.6.1 Hospira Company Details
12.6.2 Company Description and Business Overview
12.6.3 Biosimilar of Remicade Introduction
12.6.4 Hospira Revenue in Biosimilar of Remicade Business (2013-2018)
12.6.5 Hospira Recent Development
12.7 Merck Serono (Merck Group)
12.7.1 Merck Serono (Merck Group) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Biosimilar of Remicade Introduction
12.7.4 Merck Serono (Merck Group) Revenue in Biosimilar of Remicade Business (2013-2018)
12.7.5 Merck Serono (Merck Group) Recent Development
12.8 Biogen idec Inc.
12.8.1 Biogen idec Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Biosimilar of Remicade Introduction
12.8.4 Biogen idec Inc. Revenue in Biosimilar of Remicade Business (2013-2018)
12.8.5 Biogen idec Inc. Recent Development
12.9 Genentech (Roche Group)
12.9.1 Genentech (Roche Group) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Biosimilar of Remicade Introduction
12.9.4 Genentech (Roche Group) Revenue in Biosimilar of Remicade Business (2013-2018)
12.9.5 Genentech (Roche Group) Recent Development

13 Market Forecast 2018-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2018-2025)
13.10 Market Size Forecast by Application (2018-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Table

List of Tables and Figures

Table Biosimilar of Remicade Key Market Segments
Table Key Players Biosimilar of Remicade Covered
Table Global Biosimilar of Remicade Market Size Growth Rate by Type 2013-2025 (Million US$)
Figure Global Biosimilar of Remicade Market Size Market Share by Type 2013-2025
Figure 100mg/10ml Figures
Table Key Players of 100mg/10ml
Figure 500mg/50ml Figures
Table Key Players of 500mg/50ml
Table Global Biosimilar of Remicade Market Size Growth by Application 2013-2025 (Million US$)
Figure Blood Disorders Case Studies
Figure Oncology Diseases Case Studies
Figure Biosimilar of Remicade Report Years Considered
Table Global Biosimilar of Remicade Market Size 2013-2025 (Million US$)
Figure Global Biosimilar of Remicade Market Size and Growth Rate 2013-2025 (Million US$)
Table Global Biosimilar of Remicade Market Size by Regions 2013-2025 (Million US$)
Table Global Biosimilar of Remicade Market Size by Regions 2013-2018 (Million US$)
Table Global Biosimilar of Remicade Market Share by Regions 2013-2018
Figure Global Biosimilar of Remicade Market Share by Regions 2013-2018
Figure Global Biosimilar of Remicade Market Share by Regions 2018
Table Market Top Trends
Table Global Biosimilar of Remicade Revenue by Manufacturers (2013-2018) (Million US$)
Table Global Biosimilar of Remicade Market Share by Manufacturers (2013-2018)
Figure Global Biosimilar of Remicade Market Share by Manufacturers in 2018
Table Global Biosimilar of Remicade Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Biosimilar of Remicade Product/Solution/Service
Table Date of Enter into Biosimilar of Remicade Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Biosimilar of Remicade Market Size by Type (2013-2018) (Million US$)
Table Global Biosimilar of Remicade Market Size Share by Type (2013-2018)
Figure Global Biosimilar of Remicade Market Size Market Share by Type (2013-2018)
Table Global Biosimilar of Remicade Market Size by Application (2013-2018) (Million US$)
Table Global Biosimilar of Remicade Market Size Share by Application (2013-2018)
Figure Global Biosimilar of Remicade Market Size Market Share by Application (2013-2018)
Figure Global Biosimilar of Remicade Revenue Market Share by Application in 2017
Figure United States Biosimilar of Remicade Market Size 2013-2018 (Million US$)
Table United States Key Players Biosimilar of Remicade Revenue (2017-2018) (Million US$)
Table United States Key Players Biosimilar of Remicade Market Share (2017-2018)
Table United States Biosimilar of Remicade Market Size by Type (2013-2018) (Million US$)
Table United States Biosimilar of Remicade Market Share by Type (2013-2018)
Table United States Biosimilar of Remicade Market Size by Application (2013-2018) (Million US$)
Table United States Biosimilar of Remicade Market Share by Application (2013-2018)
Figure Europe Biosimilar of Remicade Market Size 2013-2018 (Million US$)
Table Europe Key Players Biosimilar of Remicade Revenue (2017-2018) (Million US$)
Table Europe Key Players Biosimilar of Remicade Market Share (2017-2018)
Table Europe Biosimilar of Remicade Market Size by Type (2013-2018) (Million US$)
Table Europe Biosimilar of Remicade Market Share by Type (2013-2018)
Table Europe Biosimilar of Remicade Market Size by Application (2013-2018) (Million US$)
Table Europe Biosimilar of Remicade Market Share by Application (2013-2018)
Figure China Biosimilar of Remicade Market Size 2013-2018 (Million US$)
Table China Key Players Biosimilar of Remicade Revenue (2017-2018) (Million US$)
Table China Key Players Biosimilar of Remicade Market Share (2017-2018)
Table China Biosimilar of Remicade Market Size by Type (2013-2018) (Million US$)
Table China Biosimilar of Remicade Market Share by Type (2013-2018)
Table China Biosimilar of Remicade Market Size by Application (2013-2018) (Million US$)
Table China Biosimilar of Remicade Market Share by Application (2013-2018)
Figure Japan Biosimilar of Remicade Market Size 2013-2018 (Million US$)
Table Japan Key Players Biosimilar of Remicade Revenue (2017-2018) (Million US$)
Table Japan Key Players Biosimilar of Remicade Market Share (2017-2018)
Table Japan Biosimilar of Remicade Market Size by Type (2013-2018) (Million US$)
Table Japan Biosimilar of Remicade Market Share by Type (2013-2018)
Table Japan Biosimilar of Remicade Market Size by Application (2013-2018) (Million US$)
Table Japan Biosimilar of Remicade Market Share by Application (2013-2018)
Figure Southeast Asia Biosimilar of Remicade Market Size 2013-2018 (Million US$)
Table Southeast Asia Key Players Biosimilar of Remicade Revenue (2017-2018) (Million US$)
Table Southeast Asia Key Players Biosimilar of Remicade Market Share (2017-2018)
Table Southeast Asia Biosimilar of Remicade Market Size by Type (2013-2018) (Million US$)
Table Southeast Asia Biosimilar of Remicade Market Share by Type (2013-2018)
Table Southeast Asia Biosimilar of Remicade Market Size by Application (2013-2018) (Million US$)
Table Southeast Asia Biosimilar of Remicade Market Share by Application (2013-2018)
Figure India Biosimilar of Remicade Market Size 2013-2018 (Million US$)
Table India Key Players Biosimilar of Remicade Revenue (2017-2018) (Million US$)
Table India Key Players Biosimilar of Remicade Market Share (2017-2018)
Table India Biosimilar of Remicade Market Size by Type (2013-2018) (Million US$)
Table India Biosimilar of Remicade Market Share by Type (2013-2018)
Table India Biosimilar of Remicade Market Size by Application (2013-2018) (Million US$)
Table India Biosimilar of Remicade Market Share by Application (2013-2018)
Figure Central & South America Biosimilar of Remicade Market Size 2013-2018 (Million US$)
Table Central & South America Key Players Biosimilar of Remicade Revenue (2017-2018) (Million US$)
Table Central & South America Key Players Biosimilar of Remicade Market Share (2017-2018)
Table Central & South America Biosimilar of Remicade Market Size by Type (2013-2018) (Million US$)
Table Central & South America Biosimilar of Remicade Market Share by Type (2013-2018)
Table Central & South America Biosimilar of Remicade Market Size by Application (2013-2018) (Million US$)
Table Central & South America Biosimilar of Remicade Market Share by Application (2013-2018)
Table Synthon Pharmaceuticals Company Details
Table Synthon Pharmaceuticals Revenue in Biosimilar of Remicade Business (2013-2018) (Million US$)
Figure Synthon Pharmaceuticals Revenue Growth Rate in Biosimilar of Remicade Business (2013-2018)
Table Synthon Pharmaceuticals Recent Development
Table LG Life Sciences Company Details
Table LG Life Sciences Revenue in Biosimilar of Remicade Business (2013-2018)(Million US$)
Figure LG Life Sciences Revenue Growth Rate in Biosimilar of Remicade Business (2013-2018)
Table LG Life Sciences Recent Development
Table Novartis (Sandoz) Company Details
Table Novartis (Sandoz) Revenue in Biosimilar of Remicade Business (2013-2018)(Million US$)
Figure Novartis (Sandoz) Revenue Growth Rate in Biosimilar of Remicade Business (2013-2018)
Table Novartis (Sandoz) Recent Development
Table Celltrion Company Details
Table Celltrion Revenue in Biosimilar of Remicade Business (2013-2018)(Million US$)
Figure Celltrion Revenue Growth Rate in Biosimilar of Remicade Business (2013-2018)
Table Celltrion Recent Development
Table Biocon Company Details
Table Biocon Revenue in Biosimilar of Remicade Business (2013-2018)(Million US$)
Figure Biocon Revenue Growth Rate in Biosimilar of Remicade Business (2013-2018)
Table Biocon Recent Development
Table Hospira Company Details
Table Hospira Revenue in Biosimilar of Remicade Business (2013-2018)(Million US$)
Figure Hospira Revenue Growth Rate in Biosimilar of Remicade Business (2013-2018)
Table Hospira Recent Development
Table Merck Serono (Merck Group) Company Details
Table Merck Serono (Merck Group) Revenue in Biosimilar of Remicade Business (2013-2018)(Million US$)
Figure Merck Serono (Merck Group) Revenue Growth Rate in Biosimilar of Remicade Business (2013-2018)
Table Merck Serono (Merck Group) Recent Development
Table Biogen idec Inc. Company Details
Table Biogen idec Inc. Revenue in Biosimilar of Remicade Business (2013-2018)(Million US$)
Figure Biogen idec Inc. Revenue Growth Rate in Biosimilar of Remicade Business (2013-2018)
Table Biogen idec Inc. Recent Development
Table Genentech (Roche Group) Company Details
Table Genentech (Roche Group) Revenue in Biosimilar of Remicade Business (2013-2018)(Million US$)
Figure Genentech (Roche Group) Revenue Growth Rate in Biosimilar of Remicade Business (2013-2018)
Table Genentech (Roche Group) Recent Development
Table Global Biosimilar of Remicade Market Size by Regions (Million US$) 2018-2025
Figure Global Biosimilar of Remicade Market Size Share by Regions (2018-2025)
Figure Global Biosimilar of Remicade Market Size Share by Regions in 2025
Figure United States Biosimilar of Remicade Market Size Forecast (2018-2025)(Million USD)
Figure Europe Biosimilar of Remicade Market Size Forecast (2018-2025)(Million USD)
Figure China Biosimilar of Remicade Market Size Forecast (2018-2025)(Million USD)
Figure Japan Biosimilar of Remicade Market Size Forecast (2018-2025)(Million USD)
Figure Southeast Asia Biosimilar of Remicade Market Size Forecast (2018-2025)(Million USD)
Figure India Biosimilar of Remicade Market Size Forecast (2018-2025)(Million USD)
Figure Central & South America Biosimilar of Remicade Market Size Forecast (2018-2025)(Million USD)
Table Global Biosimilar of Remicade Market Size by Product (2018-2025) (Million US$)
Figure Global Biosimilar of Remicade Market Size by Product (2018-2025)
Figure Global Biosimilar of Remicade Market Size by Product in 2025
Table Global Biosimilar of Remicade Market Size by Application (2018-2025) (Million US$)
Figure Global Biosimilar of Remicade Market Size by Application (2018-2025)
Figure Global Biosimilar of Remicade Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *